Clinical Trial Update: Reduction of Smoking in Cardiac Disease Patients [Phase 2]

View source ↗

Summary

This Phase 2 trial sponsored by NIDA assessed reduction of smoking in patients with cardiovascular disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Tobacco Use Disorder

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cardiovascular Disease, Tobacco Use Disorder | Phase 2 | Status: COMPLETED